Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effect of Lactobacillus Rhamnosus (LGG®) on the Defence Against Pathogens in the Upper Respiratory Tract in Healthy Children - a Single-center, Randomized, Double-blind, Placebo-controlled Study With 16 Weeks Intervention.

NCT03636191 is registered in ClinicalTrials.gov with Chr Hansen as lead sponsor.

NCT NCT03636191
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03636191 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effect of Lactobacillus Rhamnosus (LGG®) on the Defence Against Pathogens in the Upper Respiratory Tract in Healthy Children - a Single-center, Randomized, Double-blind, Placebo-controlled Study With 16 Weeks Intervention.
Lead sponsor
Chr Hansen
Phase
Not applicable
Overall status
Completed
Start date
September 1, 2018
Completion date
August 30, 2019
Enrollment
619 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

infections, upper respiratory tract